Today's Top Health News Story

Did Sanofi, WHO ignore warning signals on dengue vaccine?

CHICAGO/LONDON (Reuters) - When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease. Learn More

 

More Top Health Stories

Philippines' Duterte says dengue campaign carried out in 'good faith'

MANILA (Reuters) - President Rodrigo Duterte believes the previous Philippine government acted in good faith in launching an immunization drive that used a new dengue vaccine on hundreds of thousands of children, he said on Wednesday. More »

 

Half of world's people can't get basic health services: WHO

LONDON (Reuters) - At least half the world's population is unable to access essential health services and many others are forced into extreme poverty by having to pay for healthcare they cannot afford, the World Health Organization said on Wednesday. More »

 

Republicans propose to delay, pause Obamacare taxes

WASHINGTON (Reuters) - U.S. House Republicans proposed on Tuesday to delay or suspend several taxes under former President Barack Obama's healthcare law, including a tax on medical devices and the so-called "Cadillac" tax on generous health insurance plans. More »

 

L'Oreal turns to plant-based hair dye as natural cosmetics thrive

PARIS (Reuters) - L'Oreal is launching its first wholly plant-based hair dye as cosmetics companies look to win over customers who are becoming increasingly wary of chemical ingredients. More »

 

U.S. judge questions Trump administration on birth control rules

OAKLAND, Calif. (Reuters) - A U.S. judge questioned on Tuesday whether the federal government properly formulated new rules that undermine an Obamacare requirement for employers to provide insurance that covers women's birth control. More »

 

France's Sanofi pins hopes on new drugs after setbacks

PARIS (Reuters) - French pharmaceuticals group Sanofi said on Wednesday it had suffered from low uptake for a new cholesterol drug and from concerns about a dengue vaccine, but expressed confidence its pipeline of new products would support long-term growth. More »

 

EU renews approval for herbicide glyphosate for five years

BRUSSELS (Reuters) - The European Commission said on Tuesday it had renewed for five years the license for the weed-killer glyphosate, a key ingredient in Monsanto Co's top-selling Roundup, following a heated debate over whether it causes cancer. More »

 

Aurora Cannabis wins rights for licensing talks with CannaRoyalty

(Reuters) - Canadian medical marijuana maker Aurora Cannabis Inc has won the rights to negotiate a licensing deal with CannaRoyalty Corp that will allow it to sell a range of cannabis-infused consumer products. More »

 

Israel's Teva to cut jobs in restructuring on Thursday: report

TEL AVIV (Reuters) - Israel-based Teva Pharmaceutical Industries will unveil a restructuring plan on Thursday that will include laying off more than half its Israeli workforce, the Calcalist financial news website said. More »

 

News, Photo and Web Search